As has been said earlier, unfortunately this type of situation is not uncommon.
I would combine some of the advice above.
Collate your observations and findings into an internal report. Distribute it to your manager and other key people in the organisation that would understand the implications of what your report says. You may want to use careful wording in the report so as to describe the situation and the relevant regulations without making accusations.
In this way you begin the discussions about the issues and also give responsibility for taking actions to those that have authority in the company, obviously I am assuming you are not Head of QA or RA!
If this does not provide the necessary support you need then you should consider your next move, maybe to the next company.
If you go forward with the 510k, do it as a catch-up submission and include all of the changes. Again you can be careful with how you present the information, in a way that you do not deceive the regulator, but also do not advertise the companies lack of rigour, the FDA will probably work out what has gone on and act accordingly without you jeopardising you position.
I would combine some of the advice above.
Collate your observations and findings into an internal report. Distribute it to your manager and other key people in the organisation that would understand the implications of what your report says. You may want to use careful wording in the report so as to describe the situation and the relevant regulations without making accusations.
In this way you begin the discussions about the issues and also give responsibility for taking actions to those that have authority in the company, obviously I am assuming you are not Head of QA or RA!
If this does not provide the necessary support you need then you should consider your next move, maybe to the next company.
If you go forward with the 510k, do it as a catch-up submission and include all of the changes. Again you can be careful with how you present the information, in a way that you do not deceive the regulator, but also do not advertise the companies lack of rigour, the FDA will probably work out what has gone on and act accordingly without you jeopardising you position.